Jul 23, 2021 | Webinar

Frequently asked questions in the management of urothelial cancer

Urinary biomarkers: Are we prepared to replace cystoscopies?

Watch the webinar presentations by Dr. Fernando Lozano and Dr. Alberto Breda

On June 7, 2021, HM Hospitales (Spain) organised the webinar “Frequently asked questions in the management of urothelial cancer”. This webinar included 2 presentations addressing the question “Urinary biomarkers: Are we prepared to replace cystoscopies?”:

Urinary biomarkers in bladder cancer, presented by Dr. Fernando Lozano (Vall d’Hebron Barcelona Hospital Campus)
Urinary biomarkers in upper urinary tract urothelial carcinoma (UTUC), presented Dr. Alberto Breda (Fundació Puigvert Barcelona)

Download the free slide resource and brochure

Share this on your favourite network:

All updates

Other updates

Exploring the benefits of urinary biomarkers in NMIBC surveillance

Apr 30, 2024 | Interview

Watch the interviews with expert urologists Dr. Félix Guerrero-Ramos and Prof. Dr. Fred Witjes sharing their clinical experiences about alternating cystoscopies with urinary biomarkers in the follow-up schedule of patients with non-muscle-invasive bladder cancer...

The diagnostic value of urinary biomarkers in UTUC

Feb 2, 2024 | Publication

Reviewed by Mr. Hugh Mostafid (Royal Surrey County Hospital, Guildford, UK) UTUC: similarities and differences compared to bladder cancer While bladder tumours account for 90-95% of all urothelial carcinomas (UCa), only 5-10% of UCa cases involve the upper urinary...

Including Bladder EpiCheck® in NMIBC surveillance leads to a major reduction in healthcare costs

Jan 19, 2024 | Publication

Urinary biomarker tests, including Bladder EpiCheck®, are reimbursed from January 2024 in the Netherlands Reviewed by Prof. Joost Boormans (Erasmus MC Cancer Institute, Rotterdam, The Netherlands) Pitfalls of the current standard for NMIBC follow-up Due to the high...

Privacy policy

Disclaimers

✉ info@bcamonitor.org